Chinese biopharmaceutical firm Abbisko pocketed HK$1.75bn this week by pricing its IPO at the top of the marketed range, helped by a large group of cornerstone investors, according to a source close …
( read original story …)
The Shanghai News
Chinese biopharmaceutical firm Abbisko pocketed HK$1.75bn this week by pricing its IPO at the top of the marketed range, helped by a large group of cornerstone investors, according to a source close …
( read original story …)